Fund managers explain why they are going against the herd with their stock, sector and country allocations.
John William Olsen, manager, M&G Global Growth fund Indivior Indivior is a single-product pharma company producing addiction cessation treatments. It was created at the end of last year from the spin-off of the pharmaceuticals division of Reckitt Benckiser. A few things occurred at the time that created a genuine contrarian opportunity. The spin-off happened on 23 December when a lot of market participants were on holiday, so volumes were low and Indivior subsequently dropped out of the FTSE 100, causing index trackers to sell out. Plus, a number of investors in ...
To continue reading this article...
Join Investment Week for free
Signup and gain exclusive members-only insights - all free of charge!
- Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
- Get ahead of regulatory and technological changes affecting fund management
- Important and breaking news stories selected by the editors delivered straight to your inbox each day
- Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
- Be the first to hear about our extensive events schedule and awards programmes
